Company page

Cartesian Therapeutics, Inc.

Cartesian Therapeutics, Inc. is a public company traded under the ticker RNAC in the American market, with a market capitalization of approximately $282.9 million. The company focuses on developing innovative therapies to address unmet medical needs. Cartesian Therapeutics is committed to advancing its pipeline of treatments to improve patient outcomes.